Literature DB >> 23470004

Applications of mesoporous materials as excipients for innovative drug delivery and formulation.

Shou-Cang Shen1, Wai Kiong Ng, Leonard Sze Onn Chia, Yuan-Cai Dong, Reginald Beng Hee Tan.   

Abstract

Due to uniquely ordered nanoporous structure and high surface area as well as large pore volume, mesoporous materials have exhibited excellent performance in both controlled drug delivery with sustained release profiles and formulation of poorly aqueoussoluble drugs with enhanced bioavailability. Compared with other bulk excipients, mesoporous materials could achieve a higher loading of active ingredients and a tunable drug release profile, as the high surface density of surface hydroxyl groups offered versatility to be functionalized. With drug molecules stored in nano sized channels, the pore openings could be modified using functional polymers or nano-valves performing as stimuli-responsive release devices and the drug release could be triggered by environmental changes or other external effects. In particular, mesoporous silica nanoparticles (MSN) have attracted much attention for application in functional target drug delivery to the cancer cell. The smart nano-vehicles for drug delivery have showed obvious improvements in the therapeutic efficacy for tumor suppression as compared with conventional sustained release systems, although further progress is still needed for eventual clinical applications. Alternatively, unmodified mesoporous silica also exhibited feasible application for direct formulation of poorly water-soluble drugs to enhance dissolution rate, solubility and thus increase the bioavailability after administration. In summary, mesoporous materials offer great versatility that can be used both for on-demand oral and local drug delivery, and scientists are making great efforts to design and fabricate innovative drug delivery systems based on mesoporous drug carriers.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23470004     DOI: 10.2174/1381612811319350005

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  5 in total

1.  Effect of gamma irradiation on drug releasing from nano-bioactive glass.

Authors:  M M Farag; W M Abd-Allah; A M Ibrahim
Journal:  Drug Deliv Transl Res       Date:  2015-02       Impact factor: 4.617

2.  Nanostructured SBA-15 host applied in ketorolac tromethamine release system.

Authors:  Jorgelina Cussa; Juliana M Juárez; Marcos B Gómez Costa; Oscar A Anunziata
Journal:  J Mater Sci Mater Med       Date:  2017-06-17       Impact factor: 3.896

3.  Amino-Functionalized Mesoporous Silica Nanoparticle-Encapsulated Octahedral Organoruthenium Complex as an Efficient Platform for Combatting Cancer.

Authors:  Marina Martínez-Carmona; Quy P Ho; Jérémy Morand; Ana García; Enrique Ortega; Luiza C S Erthal; Eduardo Ruiz-Hernandez; M Dolores Santana; José Ruiz; Maria Vallet-Regí; Yurii K Gun'ko
Journal:  Inorg Chem       Date:  2020-07-06       Impact factor: 5.165

4.  Improving anti-tumor activity of sorafenib tosylate by lipid- and polymer-coated nanomatrix.

Authors:  Yang Guo; Ting Zhong; Xiao-Chuan Duan; Shuang Zhang; Xin Yao; Yi-Fan Yin; Dan Huang; Wei Ren; Qiang Zhang; Xuan Zhang
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

5.  Enhancing the dissolution of phenylbutazone using Syloid® based mesoporous silicas for oral equine applications.

Authors:  Laura J Waters; John P Hanrahan; Joseph M Tobin; Catherine V Finch; Gareth M B Parkes; Shamsuddeen A Ahmad; Faraj Mohammad; Maria Saleem
Journal:  J Pharm Anal       Date:  2018-01-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.